Introduction
Neuropilin-1 (NP-1) is an alternative receptor for vascular endothelial growth factor (VEGF) (Soker et al., 1998) . NP-1 functions as a coreceptor to VEGF receptor-2 (VEGFR-2), the main receptor for VEGF on vascular endothelial cells (EC) (Petrova et al., 1999) . NP-1 potentiates the effects of VEGF-A(165) binding to VEGFR-2 by increasing the cellular response to VEGF (Soker et al., 1998) and by generating a stronger VEGFR-2 signal (Ballmer-Hofer et al., 2011) . Among the VEGF family members, VEGF-A is the strongest apoptosis-inhibiting factor of EC with several splice variants (121, 145, 165, 189 , and 206 amino acids) that show different receptor affinities. VEGF-A(165) promotes EC survival, proliferation and migration, but also vascular permeability (Zachary, 2001) . The cerebrovascular endothelium is prominently involved in Abbreviations: A7R, neuropilin-1 inhibitor [ATWLPPR]; Bcl-2, B-cell lymphoma 2 protein; BSA, bovine serum albumin; cRGDfV, αV-integrin inhibitor cyclo-[Arg-GlyAsp-D-Phe-Val]; EC, endothelial cells; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; %HLV ec , edema-corrected ischemic lesion volume; HUVEC, human umbilical vein endothelial cells; IR, ischemia-reperfusion model; IO, ischemia-occlusion model; ISL assay, in situ-ligation assay; MCAO, middle cerebral artery occlusion; NF-κB, nuclear factor κ-light-chain-enhancer of activated B-cells; NP-1, neuropilin-1; PARP, poly(ADP-ribose)-polymerase; PAS, periodic acid-Schiff reaction staining; SOD-1, superoxide dismutase-1; STATs, signal transducers and activators of transcription; SU5416, tyrosine-kinase inhibitor of vascular endothelial growth factor receptor-2 [3-[(2,4-di-methylpyrrol-5-yl)-methylidene]-indolin-2-one]; VEGF, vascular endothelial growth factor; VEGFR-2, vascular endothelial growth factor receptor-2.
